AAAAAA

   
Results: 1-7 |
Results: 7
Molecular subtypes of anaplastic oligodendroglioma: Implications for patient management at diagnosis
Authors: Ino, Y Betensky, RA Zlatescu, MC Sasaki, H Macdonald, DR Stemmer-Rachamimov, AO Ramsay, DA Cairncross, JG Louis, DN
Citation: Y. Ino et al., Molecular subtypes of anaplastic oligodendroglioma: Implications for patient management at diagnosis, CLIN CANC R, 7(4), 2001, pp. 839-845
Tumor location and growth pattern correlate with genetic signature in oligodendroglial neoplasms
Authors: Zlatescu, MC TehraniYazdi, A Sasaki, H Megyesi, JF Betensky, RA Louis, DN Cairncross, JG
Citation: Mc. Zlatescu et al., Tumor location and growth pattern correlate with genetic signature in oligodendroglial neoplasms, CANCER RES, 61(18), 2001, pp. 6713-6715
Inactivation of p53 sensitizes U87MG glioma cells to 1,3-bis(2-chloroethy1)-1-nitrosourea
Authors: Xu, GW Nutt, CL Zlatescu, MC Keeney, M Chin-Yee, I Cairncross, JG
Citation: Gw. Xu et al., Inactivation of p53 sensitizes U87MG glioma cells to 1,3-bis(2-chloroethy1)-1-nitrosourea, CANCER RES, 61(10), 2001, pp. 4155-4159
PTEN is a target of chromosome 10q loss in anaplastic oligodendrogliomas and PTEN alterations are associated with poor prognosis
Authors: Sasaki, H Zlatescu, MC Betensky, RA Ino, Y Cairncross, JG Louis, DN
Citation: H. Sasaki et al., PTEN is a target of chromosome 10q loss in anaplastic oligodendrogliomas and PTEN alterations are associated with poor prognosis, AM J PATH, 159(1), 2001, pp. 359-367
Allelic loss of chromosome 1p and radiotherapy plus chemotherapy in patients with oligodendrogliomas
Authors: Bauman, GS Ino, Y Ueki, K Zlatescu, MC Fisher, BJ Macdonald, DR Stitt, L Louis, DN Cairncross, JG
Citation: Gs. Bauman et al., Allelic loss of chromosome 1p and radiotherapy plus chemotherapy in patients with oligodendrogliomas, INT J RAD O, 48(3), 2000, pp. 825-830
Long survival and therapeutic responses in patients with histologically disparate high-grade gliomas demonstrating chromosome 1p loss
Authors: Ino, Y Zlatescu, MC Sasaki, H MacDonald, DR Stemmer-Rachamimov, AO Jhung, S Ramsay, DA von Deimling, A Louis, DN Cairncross, JG
Citation: Y. Ino et al., Long survival and therapeutic responses in patients with histologically disparate high-grade gliomas demonstrating chromosome 1p loss, J NEUROSURG, 92(6), 2000, pp. 983-990
The hPMS2 exon 5 mutation and malignant glioma
Authors: Taylor, MD Perry, J Zlatescu, MC Stemmer-Rachamimov, AO Ang, LC Ino, Y Schwartz, M Becker, LE Louis, DN Cairncross, JG
Citation: Md. Taylor et al., The hPMS2 exon 5 mutation and malignant glioma, J NEUROSURG, 90(5), 1999, pp. 946-950
Risultati: 1-7 |